Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process

Transplant Proc. 1995 Feb;27(1):859-62.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal / therapeutic use*
  • CD4 Antigens / immunology*
  • Drug Administration Schedule
  • Graft Rejection / pathology
  • Graft Rejection / therapy*
  • HLA-DR Antigens / blood
  • Humans
  • Immunosuppression Therapy*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Predictive Value of Tests
  • T-Lymphocytes / immunology
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • CD4 Antigens
  • HLA-DR Antigens